Jason Laine

DEA Postpones Marijuana Rescheduling Decision, Sparking Election-Year Debate 0
- MEDICAL MARIJUANA
- December 2, 2024
The Drug Enforcement Administration (DEA) has announced a significant delay in its decision on marijuana rescheduling, pushing the timeline beyond the upcoming presidential election. According to a recent Forbes report, the DEA has scheduled a hearing for December 2 to discuss the Biden administration’s proposal to reclassify marijuana under federal drug laws. This move effectively
READ MORE
New Publication Highlights Role of Medical Cannabis in Epilepsy Treatment 0
- CANNABIS OIL
- November 25, 2024
A groundbreaking review titled Medical Cannabis & Epilepsy has been released by Maple Tree Consultants, providing a comprehensive analysis of the role of cannabis-based medicines in managing epilepsy. This publication, co-authored by experts including Professor Mike Barnes and Hannah Deacon, compiles findings from nearly 100 clinical trials and observational studies, making it an invaluable resource
READ MORE

Florida’s Medical Cannabis Market Shows Signs of Cooling 0
- MEDICAL MARIJUANA
- November 18, 2024
Recent data from Florida’s Office of Medical Marijuana Use reveals a significant slowdown in the state’s medical cannabis market. Patient growth has decelerated to a record low of 2.7% annually, down from 8.4% in late May. Despite an increase in dispensaries, the market is facing challenges with slowing revenue growth and increasing competition. Interestingly, unit
READ MORE
CBD Shows Promise in Reducing Fever and Inflammation, Study Finds 0
- CANNABIS OIL
- November 13, 2024
A groundbreaking study published in Progress in Neuropsychopharmacology & Biological Psychiatry reveals that cannabidiol (CBD) may effectively reduce fever and inflammation. Researchers at the University of São Paulo found that CBD lowered fever in mice by altering biological pathways related to stress and inflammation responses. The study, led by Professor Luiz Guilherme S. Branco, demonstrated
READ MORE